Emerald Star Holdings Revenue, Growth & Competitor Profile

DBA EMERALD STAR HOLDINGS, LLC DBA PACIFIC BIOMARKERS
DBA NEXELIS
DBA PACIFIC BIOMARKERS

Company Profile & Annual Report for Emerald Star Holdings

Access the complete profile.

Emerald Star Holdings Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	100 - 500Exact Company Size
Primary Industry	621511 Medical Laboratories
Additional NAICS Codes	54138 Testing Laboratories
Address	645 Elliot Avenue W Suite 300 Seattle, WA 98119

Note: Revenues for privately held companies are statistical evaluations.


Emerald Star Holdings's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Emerald Star Holdings's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Emerald Star Holdings is classified as operating in the Medical Laboratories industry, NAICS Code 621511.

Emerald Star Holdings Annual Revenue and Growth Rate

Emerald Star Holdings	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$10 - $100 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Emerald Star Holdings's revenues are gauged from an analysis of company filings.

Emerald Star Holdings's Income Statement (based on Industry Averages)

Emerald Star Holdings P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Emerald Star Holdings is developing and marketing. Emerald Star Holdings doesn't have any recent trademark applications, indicating Emerald Star Holdings is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
PACBIOMARKERS research and development in the field of drug development	05/19/2015
BIOMARKER NAVIGATOR Computer software to maintain, manage, access, manipulate and analyze data for use in the field of drug development	05/19/2015
PB computer software to maintain, manage, access, manipulate and analyze data for use in the field of drug development	05/19/2015

See all trademarks and details in the Full Report.

Market Share of Emerald Star Holdings's Largest Competitors

A competitive analysis shows these companies are in the same general field as Emerald Star Holdings, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
PHYSICIANS IMMUNODIAGNOSTIC LABORATORY	Burbank, CA	100
ACCU REFERENCE MEDICAL LAB LIMITED LIABILITY	Linden, NJ	100
CENTOGENE US	Cambridge, MA	88
LATARA ENTERPRISE	Pomona, CA	61
TELIGENT PHARMA	Vineland, NJ	46
COVID CLINIC	Huntington Beach, CA	37
VIKOR SCIENTIFIC	Charleston, SC	33
BIOTHERANOSTICS	San Diego, CA	31
SHERMAN-ABRAMS LABORATORY	Brooklyn, NY	31

Nearby Competitors

These companies are similar in business line and location to Emerald Star Holdings. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
CELLNETIX LABS	Tukwila, WA	100
HEMATOLOGICS	Seattle, WA	10
EMERALD STAR HOLDINGS	Seattle, WA	10
A1A	Seattle, WA	8
CUREVO	Seattle, WA	7
ATLAS GENOMICS	Seattle, WA	6

Future Competition: Emerald Star Holdings's Fastest Growing Competitors

These companies are in the same general field as Emerald Star Holdings and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)